SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001347613-18-000014
Filing Date
2018-05-10
Accepted
2018-05-10 16:32:40
Documents
60
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgyp-33118x10q.htm 10-Q 491140
2 EXHIBIT 31.1 sgyp-ex311x33118x10q.htm EX-31.1 11863
3 EXHIBIT 31.2 sgyp-ex312x33118x10q.htm EX-31.2 11936
4 EXHIBIT 32.1 sgyp-ex321x33118x10q.htm EX-32.1 6750
5 EXHIBIT 32.2 sgyp-ex322x33118x10q.htm EX-32.2 7476
  Complete submission text file 0001347613-18-000014.txt   3743672

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20180331.xml EX-101.INS 604205
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20180331.xsd EX-101.SCH 36518
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20180331_cal.xml EX-101.CAL 56534
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20180331_def.xml EX-101.DEF 212973
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20180331_lab.xml EX-101.LAB 510289
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20180331_pre.xml EX-101.PRE 316165
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 18823066
SIC: 2834 Pharmaceutical Preparations